The Catholic Univ. of Korea Bucheon St. Mary's Hospital
Welcome,         Profile    Billing    Logout  
 0 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kim, Sungrae
NCT05378503: Phase IV Study of Qsymia in Obese Patients

Completed
4
232
RoW
Qsymia 3.75Mg-23Mg Extended Release Capsule, Low dose titration, Qsymia 7.5Mg-46Mg Extended Release Capsule, Low dose maintenance, Qsymia 11.25Mg-69Mg Extended Release Capsule, High dose titration, Qsymia 15Mg-92Mg Extended Release Capsule, High dose maintenance, Placebo
Alvogen Korea
Obesity
10/23
10/23
NCT05226897: Clinical Trial to Assess the Efficacy and Safety of YYC405 in Type 2 Diabetes Patients

Active, not recruiting
3
256
RoW
YYC405-T, Metformin≄1000mg, Dapagliflozin 10mg, YYC405-T placebo
Yooyoung Pharmaceutical Co., Ltd.
Type 2 Diabetes
10/22
06/23
Lee, SeongSu
NCT05378503: Phase IV Study of Qsymia in Obese Patients

Completed
4
232
RoW
Qsymia 3.75Mg-23Mg Extended Release Capsule, Low dose titration, Qsymia 7.5Mg-46Mg Extended Release Capsule, Low dose maintenance, Qsymia 11.25Mg-69Mg Extended Release Capsule, High dose titration, Qsymia 15Mg-92Mg Extended Release Capsule, High dose maintenance, Placebo
Alvogen Korea
Obesity
10/23
10/23
Son, JangWon
NCT05378503: Phase IV Study of Qsymia in Obese Patients

Completed
4
232
RoW
Qsymia 3.75Mg-23Mg Extended Release Capsule, Low dose titration, Qsymia 7.5Mg-46Mg Extended Release Capsule, Low dose maintenance, Qsymia 11.25Mg-69Mg Extended Release Capsule, High dose titration, Qsymia 15Mg-92Mg Extended Release Capsule, High dose maintenance, Placebo
Alvogen Korea
Obesity
10/23
10/23

Download Options